These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30563349)

  • 21. Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier.
    Ndrepepa G; Colleran R; Kastrati A
    Coron Artery Dis; 2017 May; 28(3):253-262. PubMed ID: 28072597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
    Fabris E; Korjian S; Coller BS; Ten Berg JM; Granger CB; Gibson CM; van 't Hof AWJ
    Thromb Haemost; 2021 Dec; 121(12):1562-1573. PubMed ID: 33677829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
    Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
    J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote Ischemic Perconditioning to Reduce Reperfusion Injury During Acute ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
    McLeod SL; Iansavichene A; Cheskes S
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reperfusion in STEMI patients: still a role for cardioprotection?
    Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
    Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.
    Durante A; Laricchia A; Benedetti G; Esposito A; Margonato A; Rimoldi O; De Cobelli F; Colombo A; Camici PG
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):e005841. PubMed ID: 28592591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of myocardial functional recovery following successful reperfusion of acute ST elevation myocardial infarction.
    Shehata IE; Cheng CI; Sung PH; Ammar AS; El-Sherbiny IAE; Ghanem IGA
    Echocardiography; 2018 Oct; 35(10):1571-1578. PubMed ID: 30073720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of No Reflow with a Loading Dose of Atorvastatin before Primary Angioplasty in Patients with Acute ST Myocardial Infarction.
    García-Méndez RC; Almeida-Gutierrez E; Serrano-Cuevas L; Sánchez-Díaz JS; Rosas-Peralta M; Ortega-Ramirez JA; Palomo-Villada JA; Isordia-Salas I; Alonso-Bravo RM; Borrayo-Sanchez G
    Arch Med Res; 2018 Nov; 49(8):620-629. PubMed ID: 30446246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility.
    Lupi A; Schaffer A; Lazzero M; Tessitori M; De Martino L; Rognoni A; Bongo AS; Porto I
    Cardiovasc Revasc Med; 2016 Dec; 17(8):528-534. PubMed ID: 27666002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the "DAPT-STEMI trial".
    Kedhi E; Fabris E; van der Ent M; Kennedy MW; Buszman P; von Birgelen C; Cook S; Wedel H; Zijlstra F
    Am Heart J; 2017 Jun; 188():11-17. PubMed ID: 28577666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should STEMI Patients Receive Opiate Analgesia? The Morphine Paradox.
    Farag M; Spinthakis N; Srinivasan M; Gorog DA
    Curr Vasc Pharmacol; 2018; 16(5):477-483. PubMed ID: 29345594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Mandurino-Mirizzi A; Crimi G; Raineri C; Pica S; Ruffinazzi M; Gianni U; Repetto A; Ferlini M; Marinoni B; Leonardi S; De Servi S; Oltrona Visconti L; De Ferrari GM; Ferrario M
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):240-246. PubMed ID: 29470249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
    Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.
    Nepper-Christensen L; Lønborg J; Høfsten DE; Ahtarovski KA; Bang LE; Helqvist S; Kyhl K; Køber L; Kelbæk H; Vejlstrup N; Holmvang L; Engstrøm T
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e006842. PubMed ID: 30354595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
    Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.